SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Rhea-AI Summary
SenesTech (NASDAQ: SNES), a company focused on fertility control for managing animal pest populations and maker of EPA-compliant Rodent Birth Control products, will participate in the virtual Lytham Partners Spring 2026 Investor Conference on Thursday, May 28, 2026.
The company will deliver a webcast presentation at 2:30 p.m. ET, accessible via the conference home page or direct webinar link. The webcast will be available for replay, and management will also hold virtual one-on-one meetings with investors during the event.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – SNES
On the day this news was published, SNES gained 5.23%, reflecting a notable positive market reaction. Argus tracked a peak move of +7.9% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $466K to the company's valuation, bringing the market cap to $9.37M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SNES was down 2.52% while at least 2 tracked peers (e.g., CNEY, BGLC) also appeared in momentum scans moving down, with a median move around the mid-single-digit negatives, indicating broader sector pressure around this neutral conference update.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| May 12 | Q1 2026 results | Positive | +9.0% | Reported revenue growth, record gross margin, and strong e-commerce momentum. |
| May 07 | Earnings date notice | Neutral | -12.2% | Announced timing and webcast details for upcoming Q1 2026 results. |
| May 07 | CEO appointment | Positive | +34.0% | Named Michael Edell as President and CEO with board and leadership changes. |
| Mar 12 | FY 2025 earnings | Neutral | -15.0% | Reported 2025 growth in e-commerce, higher margins, but continued net losses. |
| Mar 09 | Earnings date notice | Neutral | -6.6% | Set date and call details for Q4 and full-year 2025 financial results. |
Recent news has often led to sizable moves: leadership and strategy updates drew strong gains, while some earnings-related items saw selling, indicating event-driven but mixed directionality.
Over the last six months, SenesTech has reported several milestones. On Mar 12, 2026, full-year 2025 results showed 20% revenue growth and improved margins but ongoing losses. Subsequent earnings-date notices on Mar 9 and May 7, 2026 preceded volatile trading. Leadership changes, including appointing Michael Edell as CEO on May 7, 2026, produced the sharpest positive reaction. The May 12, 2026 Q1 update highlighted record gross margin and strong e-commerce growth. Today’s conference participation fits into this pattern of frequent investor-facing communications.
Regulatory & Risk Context
An effective S-3 shelf filed on Aug 15, 2025 registered common stock and warrant-related shares for resale by selling stockholders. The company stated it would only receive proceeds from any cash warrant exercises, earmarked for general corporate purposes such as R&D, capital expenditures, working capital and potential acquisitions, while warning about ongoing losses and dilution risk from outstanding warrants.
Market Pulse Summary
The stock moved +5.2% in the session following this news. A strong positive reaction aligns with SenesTech’s history of sizable moves around investor-facing events and leadership updates. The conference appearance on May 28, 2026 would have followed recent insider buying and detailed Q1 disclosures, which may have reinforced confidence in the e-commerce strategy. However, investors also had to weigh ongoing losses and an existing resale shelf, factors that could temper or reverse enthusiasm if execution or funding expectations softened.
AI-generated analysis. Not financial advice.
Company Webcast
The webcast presentation will take place at 2:30 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/yq6rxLqNPWj. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2026invreg/.
About SenesTech
SenesTech is committed to creating healthier environments by managing animal pest populations through birth control. The Company's groundbreaking products, including Evolve rodent birth control, integrate seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.
For more information visit https://senestech.com/.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, statements regarding the acceleration of the Company's direct-to-consumer and e-commerce initiatives, the recurring nature of the Company's growing director-to-consumer business model, any growth attributable to the appointment of the Company's new CEO, the Company's efforts in driving B2B revenues, any increases in conversion rates and subscription growth, and any international expansion opportunities for the Company.
Forward-looking statements may describe future expectations, plans, results, or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; regulatory approval and regulation of our products; challenges transitioning to direct management of Amazon sales of Evolve products or the results of such direct management not being as expected; having to use cash at times and in ways other than as planned; and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investors: Robert Blum, Lytham Partners, LLC, (602) 889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., (928) 779-4143
View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-spring-2026-investor-conference-on-may-28-2026-302776442.html
SOURCE SenesTech, Inc.